Morphosys Ag's ROA from the fourth quarter of 2023 to the fourth quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Morphosys Ag's ROA in the fourth quarter of 2023?
Morphosys Ag recorded a cumulative net loss of $-213 million during 12 months ending in the fourth quarter of 2023, resulting in a negative return on assets (ROA) of -9.36%.

However, within the Healthcare sector 314 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2023 from to 3952.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Dec 31 2023) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2022) IV. Quarter
Y / Y Total Assets Change	-15.46 %	-15.46 %	-15.46 %	-15.46 %	-6.23 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-213	-169	-169	-169	-169
Return On Assets (TTM)	-9.36 %	-7.13 %	-6.83 %	-6.56 %	-6.3 %
MOR's Total Ranking	# 3952	#	#	#	# 4096
Total Assets (TTM) in million	2,269	2,269	2,269	2,269	2,685
Seq. Total Assets Change	0 %	0 %	0 %	-15.46 %	0 %
Seq. Net Income Change	-	-	-	-	-

MOR's 5 Years Annual ROA >> Back to MOR Management Effectiveness >> Compare MOR ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 106
Sector	# 315
Overall	# 3870

Return On Assets Statistics
High	Average	Low
5.9 %	-10.13 %	-20.75 %
(Dec 31 2020)		(Dec 31 2019)

Financial Statements
Morphosys Ag's Assets	$ 2,269 million	MOR's Balance sheet
Morphosys Ag's Income	$ -213 million	Quarterly MOR's Income Statement
MOR's Income by Division		See MOR's Income by Division

Annual Return On Assets	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021	(Dec 31 2020) FY 2020	(Dec 31 2019) FY 2019
Y / Y Total Assets Change	-15.46 %	-6.23 %	54.04 %	234.28 %	-7.86 %
Total Assets in million	2,269	2,685	2,863	1,859	556
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-213	-169	-576	110	-115
Annual Return On Assets	-9.36 %	-6.3 %	-20.13 %	5.9 %	-20.75 %

MOR's 5 Years Annual ROA >> Back to MOR Management Effectiveness >> Compare MOR ROA to its Competitors

More Return On Assets Ratios
MOR's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
MOR's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for MOR's Competitors
Subscribers only: Roa for Morphosys Ag's Suppliers
Subscribers only: Return On Assets for MOR's Customers

You may also want to know
MOR's Roi	MOR's Inventory Turnover Ratio	MOR's Growth Rates	MOR's Dividend Comparisons
	MOR's Profitability Ratios	MOR's Asset Turnover Ratio	MOR's Dividend Growth
MOR's Roe	MOR's Valuation Ratios	MOR's Financial Strength Ratios	MOR's Dividend Payout Ratio

Companies with similar Return On Assets at Dec 31 2023, within Healthcare Sector

ROA

Date modified: 2026-09-02T20:36:52+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.